Canada Pension Plan Investment Board Aeglea Bio Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 15, 2019	SELL	$7.6 - $9.4 $38,000 - $47,000	-5,000 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$6.51 - $10.19 $32,550 - $50,950	5,000 New	5,000 $37,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.